top of page

Latest News

Ivana Muncie-Vasic on the She Leads Biotech podcast

Enjoy learning more about Vitra Labs and our founder and CEO Ivana Muncie-Vasic via Sharron Cox’s recent She Leads Biotech podcast!

We are excited to welcome John Langowski as Chief Technology Officer at Vitra Labs!

John brings more than two decades of industry drug research and development experience to the role, most recently as VP of Cell Therapy Research and Foster City Site Head at Kite Pharma, a Gilead Sciences company, where he led the research infrastructure and strategic decision-making that advanced cell-based programs from discovery through IND-enabling work and into the clinic.

At Vitra Labs, John will lead the technology platform underpinning our in vitro maturation R&D, manufacturing development, and commercial readiness. We are building the first high-throughput platform to systematically optimize IVM - a phase that demands deep cell biology expertise paired with translational and process discipline. John brings both.

Welcome to Vitra Labs, John!

Ivana Muncie-Vasic at QB3

Had a fantastic time back at Gladstone giving the inside scoop on what it takes to be a founder alongside Isha Jain, Magnus Hoffmann, and Sukrit Silas. Thank you Katarina Klett (she/her) for inviting me and Alicia Roy, Ph.D. for hosting!

vitra_labs_logo_edited_edited_edited_edited_edited_edited.png

Vitra Labs, Inc. technology is in preclinical development and not yet FDA-approved. Vitra's platform is investigational and not available for clinical use. Timing and regulatory classification are anticipated and subject to change. Information on this site is for research and educational purposes only.

© 2025 Vitra Labs, Inc.

  • LinkedIn
bottom of page